Previous studies have established an association between exercise intolerance and increased morbidity and mortality in congenital heart disease patients. We aimed to clarify if exercise intolerance is associated with poor outcome in Fontan patients and to identify risk factors for mortality, transplantation, and cardiac-related hospitalization.
Introduction
Previous studies have suggested that exercise intolerance is a powerful prognostic marker in patients with congenital heart disease. 1 -3 More recently, studies have shown the prognostic value of parameters of cardiopulmonary testing in patients with a systemic right ventricle or corrected Tetralogy of Fallot. 4, 5 As a consequence, a peak oxygen uptake (peak VO 2 ) ,15 mL/kg/min or ,50% of predicted for age and sex has been recommended for consideration of congenital heart disease patients for cardiac transplantation according to current ACC/AHA guidelines (Class IIa, Level of Evidence: C). 6 Patients with Fontan physiology are affected by a multitude of complications associated with considerable morbidity and mortality, and are frequently considered possible candidates for cardiac transplantation. 7 -11 However, due to limited numbers of Fontan patients included in previous studies the prognostic value of cardiopulmonary testing in these patients is unknown. This retrospective study included all Fontan patients who underwent cardiopulmonary exercise testing (CPET) with gas exchange monitoring at four major European centres for congenital heart disease between 1997 and 2008. All centres have long-standing experience with CPET in patients with congenital heart disease and have collaborated on cardiopulmonary exercise studies previously. 4, 5, 12 In addition to parameters of exercise testing, the prognostic value of simple baseline clinical information such as the morphology of the single ventricle, symptoms, functional class, type of surgery, the presence of clinically relevant arrhythmias, and signs and symptoms of heart failure were considered.
Methods
This was a multicentre retrospective investigation. Across the four institutions involved, all Fontan patients who are able to exercise undergo routine CPET as part of their regular clinical follow-up. All Fontan patients who underwent a cardiopulmonary exercise test between April 1997 and December 2008 were included. In patients who underwent more than one test during the study period, only the first test was considered. Patients with a partial cavopulmonary anastomosis (i.e. Glenn-type palliation) were excluded from the present study. Based on the type of Fontan operation, patients were classified as atriopulmonary Fontan, atrioventricular Fontan, lateral tunnel total cavopulmonary anastomosis, or extracardiac conduit total cavopulmonary connection (TCPC). In addition to parameters of CPET, the following variables potentially associated with outcome were studied: a history of clinically relevant (usually supraventricular) arrhythmia, history of decompensated heart failure requiring diuretic therapy, morphology of the functional single ventricle, and previous palliations. Clinically relevant arrhythmia was defined based on symptoms, documentation, and need for chronic antiarrhythmic medication. 13 Informed consent was obtained from all patients before undergoing exercise testing. The institutional committees on human research approved the present retrospective study.
Follow-up and analysis of survival status and hospitalization
The primary endpoint of the study was a combined endpoint of death or cardiac transplantation. To assess morbidity, we also investigated an endpoint of cardiac-related hospital admissions. Cardiac-related hospital admissions were defined as any admission directly caused by heart failure requiring inpatient care or arrhythmia requiring hospital treatment. In addition, complications characteristic of the Fontan circulation such as protein losing enteropathy were classified as cardiac-related hospitalizations for the scope of the study. Following the exercise test, all patients were regularly followed up for cardiac-related events at their respective institutions, providing for a high likelihood that all cardiac events would have been recorded. Additionally, patients' medical records were reviewed to obtain information on reasons for hospitalization and patients' survival status. Survival status was further ascertained from phone interviews with patients' primary care physicians. No patient was lost to follow-up during the follow-up period.
Cardiopulmonary exercise test
Exercise tests were performed on an electronically braked ergometer cycle (n ¼ 236) or on a treadmill (n ¼ 85). Carbon dioxide elimination, VO 2 , and minute ventilation were measured with a computerized breath-by-breath analyser. Patients performed a symptom-limited maximal exercise test using an incremental protocol that allowed reaching exhaustion in 10 min of exercise. A 12-lead electrocardiogram and transcutaneous oxygen saturation were also continuously monitored throughout the study, and blood pressure was determined manually every 2 min. The technical details of measurement of peak VO 2 and VE/VCO 2 -slope have been published. 1, 3, 12 Resting heart rate was measured after at least 2 min of complete rest in a seated position, whereas peak heart rate was defined as the maximal heart rate achieved during exercise. Heart rate reserve was calculated as the difference between peak and resting heart rates. 2 Standard equations were used to generate predicted values for peak exercise parameters. 14 Because of age-related differences of normal peak VO 2 when expressed in mL/ kg/min, peak VO 2 was also expressed as % of predicted value. 15 Anaerobic threshold was determined according to Beaver et al.
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Statistical analysis
Values are presented as mean + standard deviation (SD) or median and inter-quartile range (IQR; 25th and 75th percentile 18 The comparative importance and additional value of the clinical score and parameters of cardiopulmonary exercise test were also assessed with a random survival forest method using the prediction error, which is conceptually similar to the area under the receiver curve as described in detail previously. 19, 20 In addition, rank-hazard plots were constructed to visualize the relative importance of covariates in a proportional hazards model. 21 
Results
Patient characteristics
The study cohort consisted of 321 patients (152 from the German Heart Centre Munich, 85 from the Royal Brompton Hospital London, 54 from the University Hospital Bologna, and 30 from the Great Ormond Street Hospital London) with a mean age of 21 + 9 years. 
Cardiopulmonary exercise testing
Peak VO 2 was markedly reduced in Fontan patients. Only 2.7% of patients had a borderline (i.e. 80-90% of predicted) and only 1% of patients had a normal peak VO 2 as shown in Figure 1 . No significant difference in peak VO 2 was found between patients with atriopulmonary/atrioventricular Fontan and those with lateral tunnel or extracardiac conduit TCPC.
Survival and cardiac transplantation
During a median follow-up of 21 months (IQR 14 -42 months), 22 patients died (6.9%) and 6 patients (1.9%) underwent cardiac transplantation due to severe heart failure. As illustrated in Figure 2A , almost all patients who died or required cardiac transplantation had undergone an atriopulmonary or atrioventricular Fontan, whereas only three patients with TCPC died (1.8%) and two required cardiac transplantation (1.2%, P , 0.0001). To investigate the possibility that younger age confounded this association and accounted for a better outcome in the TCPC group, bivariate Cox proportional-hazard analyses were performed. The type of Fontan operation was found to be significantly related to the risk of death or transplantation independent of age [P ¼ 0.009, hazard ratio 3.7 (95% CI 1.4-9.6)] in this analysis. The leading mode of death was sudden, presumably arrhythmic in 29% of patients followed by heart failure (28%), and perioperative mortality during conversion to TCPC prompted by late sequaelae of atriopulmonary or atrioventricular Fontan (19%) as illustrated in Figure 2B .
Hospitalization for cardiac reasons/ Fontan complications
Overall, 41% of patients were hospitalized for cardiac-related reasons during follow-up. Again, patients with atriopulmonary or atrioventricular Fontan had a significantly higher risk of cardiac-related hospitalization compared with TCPC patients [hazard ratio 1.7 (95% CI 1.17-2.50), P ¼ 0.004] as shown in Figure 2C . 
Prognostic value of parameters of cardiopulmonary exercise testing
All parameters of CPETwere strongly related to cardiac-related hospitalization ( Table 2) . On Cox proportional-hazards analysis, only heart rate reserve was significantly related to survival without cardiac transplantation. The association between heart rate reserve and death or transplantation was independent of the use of antiarrhythmic drugs, patient age, and type of Fontan surgery on Cox proportional-hazards analysis as shown in Table 3 . A heart rate reserve of 72 b.p.m. was identified by ROC curve analysis as the value corresponding to the highest accuracy for predicting death or need for transplantation (AUC 0.643, P ¼ 0.0077). This cut-off value was associated with a sensitivity of 88%; however, the specificity is only 38%. Peak VO 2 , percentage predicted peak VO 2 , VE/VCO 2 -slope, and anaerobic threshold were not related to death or transplantation on time-dependent ROC curve analysis or log-rank x 2 statistic maximization (data not shown). When considering only patients with a follow-up period above 3 years, no parameter of CPET was significantly related to death or transplantation (P . 0.05 for all). To account for the possibility that cyanosis may explain the lack of prognostic information provided by parameters of CPET, we performed subanalyses in patients without cyanosis and without residual right-to-left shunt lesions. However, even after excluding patients with fenestrations and shunt lesions, parameters of CPET (with the exception of heart rate reserve) were not related to outcome. The same results were obtained when patients with resting or exercise saturations ,90 or ,85% were excluded.
Prognostic value of medical history and clinical information
In contrast to most parameters of exercise testing, a history of clinically relevant cardiac arrhythmias was found to be strongly related to freedom from death or cardiac transplantation as shown in Figure 3 . Overall, 33% of patients had a history of clinically relevant arrhythmias [of these 64% were treated with a Class I or III antiarrhythmic drug, 51% with a beta-blocker (not mutually exclusive), and 4% were not medically treated because of contraindications or patient choice]. The majority of patients treated with a Class I or III antiarrhythmic drug received amiodarone (70%), whereas only a minority received sotalol (25%) or Class I drugs (5%). A strong association was also found between clinically relevant arrhythmias and cardiac-related hospitalization, as illustrated in Figure 3 . In addition, signs and symptoms of heart failure prompting diuretic therapy were strongly related to survival without transplantation or need for hospitalization for cardiac reasons. To exclude the possibility that death associated with conversion to TCPC might account for increased mortality in the atriopulmonary and atrioventricular Fontan cohort and that this may confound the prognostic value of parameters of exercise capacity, the analyses were repeated by censoring patients who underwent TCPC conversion at the time of death. Type of Fontan surgery, clinically relevant arrhythmia, heart failure symptoms requiring diuretic treatment, and heart rate reserve were confirmed as significant prognostic markers for mortality or transplantation in this analysis, whereas peak VO 2 , VE/VCO 2 -slope, and anaerobic threshold were not related to outcome. As a non-TCPC type of Fontan operation, a history of clinically relevant arrhythmia and signs and symptoms of heart failure prompting diuretic therapy were strongly related to outcome; a simple score system was constructed by combining these (readily available) clinical parameters and considering each as a risk factor for impaired prognosis. Assessing the prognostic value of the combination of these risk factors showed that patients with three risk factors had a three risk of death or transplantation of 40%, whereas patients with no risk factors had a 3-year freedom from death or transplantation of 100% as illustrated in Figure 4 . Patients with one or two risk factors had an intermediate risk of death or transplantation. The score was also found to correlate with the risk for cardiac-related hospitalization (Figure 4) . Random survival forest and rank-hazard analyses were employed to compare the prognostic value of the scoring system with that of parameters of CPET ( Figure 5 ). Both methods indicated that the simple clinical score was superior in identifying patients at risk for death or transplantation compared with parameters of CPET. In fact, the random survival forest analysis suggested that the relative prognostic value of percentage predicted peak VO 2 for death or transplantation was only 1/5 compared with that of the clinical score.
Discussion
The main findings of the study are: (i) peak VO 2 is severely impaired in contemporary Fontan patients, (ii) parameters of exercise testing relate to morbidity in this patient cohort, associated with an increased risk for cardiac-related hospitalization, whereas all assessed parameters of CPET-with the possible exception of heart rate reserve-were unrelated to mortality or cardiac transplantation, and (iii) non-TCPC type of Fontan palliation, a history of clinically relevant arrhythmia, and signs and symptoms of heart failure requiring diuretic treatment emerged as strong markers of morbidity and mortality. A combination of these (simple and readily available) factors was strongly related to outcome and outperformed any measure of CPET in estimating prognosis in the current study.
Previous studies have established that exercise intolerance is prevalent among patients with Fontan palliation. 23, 24 This is the first study to assess the association between markers of exercise capacity and outcome in Fontan patients. Although our group has previously shown that parameters of CPET are related to outcome in patients with congenital heart disease in general, 1 -3 the prognostic value of CPET in Fontan patients is unknown due to the limited number of Fontan patients included in previous studies. Combining exercise tests performed at four large European centres for adult congenital heart disease allowed us to include a sufficient number of patients and obtain adequate numbers of events to investigate this possible association. Perhaps surprisingly, no association between peak VO 2 , anaerobic threshold, or VE/VCO 2 -slope, and survival or cardiac transplantation could be established. We speculate that the inability to adequately increase pulmonary blood flow during exercise limits peak VO 2 , whereas VE/VCO 2 -slope is affected by increased dead space ventilation and lowering of the chemoreceptor set point for carbon dioxide as reported previously. 25 Thus, the abnormal values of peak VO 2 and VE/VCO 2 do not arise from the usual constellation of ominous pathophysiological abnormalities (such as poor ventricular function and vascular remodelling) but rather Figure 4 Kaplan -Meier plots according to the number of risk factors defined as non-total cavopulmonary anastomosis type of Fontan surgery, history of clinically relevant arrhythmias, and history of signs and symptoms of heart failure requiring diuretic therapy. Log-rank P-values are shown. RF, risk factor as defined above. Figure 5 (A) Relative hazard plot illustrating the relative predictive value of parameters of the clinical score (defined as non-total cavopulmonary anastomosis type of surgery, history of clinically relevant arrhythmias, and history of signs and symptoms of heart failure requiring diuretic therapy) and parameters of cardiopulmonary exercise testing. The steeper the change in relative hazard over the spectrum of the variable the higher the predictive value of the variable. (B) Relative importance of the clinical score and parameters of cardiopulmonary exercise testing in predicting prognosis based on the results of a random survival forest analysis as described in detail by Ishwaran et al. 19, 20 HRR,heart rate reserve; % pred. peak VO 2 , % predicted peak oxygen consumption.
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from an intrinsically impaired capacity to increase pulmonary blood flow adequately during exercise, increased dead space ventilation, and lowering of the chemoreceptor set point, limiting the prognostic value of parameters of CPET. This is reminiscent of patients with cyanotic congenital heart disease in whom also no prognostic value of parameters of CPET could be demonstrated in previous studies. 3 Furthermore, some Fontan patients may present with fenestrations and shunt lesions, and right-to-left shunting during exercise may further reduce the prognostic importance of exercise parameters in this setting. In contrast, increase in heart rate during exercise (heart rate reserve) was related to survival, and this association was independent of the use of antiarrhythmic drugs. This is in agreement with a previous study identifying heart rate reserve as a strong prognostic marker in adult congenital heart disease patients, including Fontan patients in a subgroup analysis. We speculate that the prognostic value of heart rate reserve may be related to the fact that unlike the other parameters of exercise testing, heart rate reserve is related to autonomic dysfunction and cardiac arrhythmias. 2,26 -28 In fact, cardiac arrhythmias are common after Fontan operation as confirmed by numerous previous studies, 29, 30 haemodynamically poorly tolerated, 31 and
were identified as a leading cause of death in the current study.
In addition, a history of clinically relevant arrhythmia was strongly associated with increased mortality or need for transplantation in our study. However, although significant on Cox proportionalhazard analysis, subsequent analyses employing rank-hazard tests and random survival forests suggested that heart rate reserve may not carry important prognostic information beyond that already available from the medical history and clinical examination. A striking difference in mortality or need for transplantation was found between patients with TCPC and those with atriopulmonary or atrioventricular Fontan. Thus, the results of the current study disagree with a recently published, single-centre study spanning 25 years of follow-up showing comparable rates of death or transplantation among all types of Fontan patients. 32 The higher rate of mortality/cardiac transplantation in patients with atriopulmonary or atrioventricular Fontan in this study is, however, in agreement with a study by d'Udekem et al. 33 In the current study, TCPC patients had significantly fewer cardiac-related hospitalizations and a lower incidence of clinically relevant arrhythmias compared with atriopulmonary or atrioventricular Fontan patients consistent with previous reports. 29, 34 Our results support the notion that atriopulmonary or atrioventricular Fontan provides more substrate for atrial arrhythmias and related morbidity and mortality over time. The onset of clinically relevant arrhythmia, generally requiring chronic antiarrhythmic therapy, emerged as an ominous prognostic sign late after Fontan operation in the present study. Due to the study design, we cannot assess the specific impact of antiarrhythmic medication on patient outcome. Whether the onset of clinical arrhythmias necessitating antiarrhythmic therapy was the primary cause or a surrogate for further progression of heart disease, our data suggest that despite therapy with Class I or Class III antiarrhythmic drugs (mainly amiodarone) in many patients, mortality rates were substantial. Further studies are required to assess whether ablation therapy-where applicable-is superior to antiarrhythmic medication and whether timely conversion atriopulmonary or atrioventricular
Fontan patients with arrhythmias (with or without arrhythmiasurgery) to TCPC would improve survival. Various studies have explored risk factors for mortality in patients with single ventricle physiology undergoing Fontan palliations. 32,35 -38 The majority of studies, however, focused on risk stratification for Fontan completion or covered long time intervals, during which one or more cardiac operations took place, thus limiting the value of these prognostic data in guiding clinical management. According to current ACC/AHA guidelines, lifelong follow-up is recommended for patients after Fontan operation and this should include a yearly evaluation at a adult congenital heart disease centre (Level of Evidence: C). 39 In addition to clinical examination, electrocardiography, chest x-ray, and echocardiography or magnetic resonance imaging to assess ventricular function, valve regurgitation, and the Fontan circuit, CPET is increasingly employed to assess objective exercise tolerance and to guide therapy. This may be useful, especially as peak VO 2 is an essential component of appropriate exercise prescription and activity guidelines. The results of the current study, however, suggest that extrapolating short-term prognosis directly from the results of a single cardiopulmonary exercise test may be inappropriate and clinicians should be aware of this limitation when using parameters of CPET as part of the decision-making process for referring Fontan patients for transplantation. The current study suggests that a clinical combined prognostic tool, taking into account type of Fontan palliation, history of clinically relevant arrhythmias, and signs and symptoms of heart failure is likely to be superior to parameters of CPET in estimating short-term prognosis. In fact, the results of the current study suggest that the relative prognostic value regarding death or transplantation of clinical information is approximately five times higher than that provided by any measure of CPET. Further studies are required to assess whether longitudinal exercise testing providing information on change in peak VO 2 over time may provide better prognostic information.
Limitations of the study
Patients with atriopulmonary Fontan were significantly older compared with TCPC patients, and despite the fact that bivariate survival analysis suggested type of Fontan surgery to be a prognostic marker independent of age, the older age of atriopulmonary Fontan is likely to account-at least in part-for the worse outcome in this cohort. The number of deaths forming the basis of this report is relatively small and future prospective studies with a longer period of observation and a higher number of clinical events are desirable to validate our report and to provide information on the potential impact of established and evolving therapies on prognosis and symptoms. Furthermore, on a conceptual basis, it is unclear why abnormal parameters of CPET are associated with an increased risk of cardiac-related hospital admission but not death or need for transplantation in the current study. Now that this discrepancy is emerging, further research may be stimulated that could elucidate the mechanisms responsible. Cardiopulmonary exercise testing in this study was performed as part of routine evaluation of Fontan patients. All patients were at tertiary adult congenital heart disease centres, and therefore, it is possible that they may not represent the pattern of adult congenital heart disease that may exist in the community. All four centres have a policy of performing periodic CPET in all Fontan patients agreeing and able to perform them. Overall, .80-90% of eligible Fontan patients under active follow-up at the centres underwent an exercise test during the study period and were included in this study. Although we cannot exclude the possibility of referral bias to the tertiary centres (potentially accounting for the observed considerable morbidity and mortality), we contend that selection bias within the centres is not likely to represent a major limitation of the current work.
Conclusion
Exercise intolerance is prevalent amongst patients with a Fontan palliation and relates to increased short-term morbidity but not increased mortality or need for cardiac transplantation in our cohort. Non-TCPC type of Fontan palliation, a history of clinically relevant arrhythmia, and signs and symptoms of heart failure were identified as strong prognosticators of morbidity and mortality. A combination of these factors was strongly related to risk of death or transplantation and was far superior to any measure of CPET in assessing outcome in the current study.
